"We are particularly excited about our partnership with Kocho. The capability to deliver leading neuro-imaging analytical services to our clients is of critical importance, as our clients seek to identify efficacious, safe drugs to address devastating neurological diseases, such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease."

“The SPA has helped us immensely to have a strategic roadmap so we can visualise what is important and prioritise accordingly. The result has been a continuous delivery of enhancements to our security posture.”